Clinical trial
Post-transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Dose Reduction: 50 mg/kg vs 25 mg/kg
NCT05780554 is registered in ClinicalTrials.gov with Centro de Hematología y Medicina Interna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Dose Reduction: 50 mg/kg vs 25 mg/kg
- Lead sponsor
- Centro de Hematología y Medicina Interna
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 10, 2023
- Completion date
- March 20, 2025
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.